← All patents

US20210315992A1

Adjuvant effect of the tlr1/2 agonist diprovocim synergizes with checkpoint- …

University of Texas Southwestern

Abstract

A potent human and mouse Toll-like receptor (TLR)1/TLR2 agonist was identified and optimized, Diprovocim, which exhibited an EC 50 of 110 pM in human THP-1 cells and 1.3 nM in primary mouse peritoneal macrophages. In mice, Diprovocim-adjuvanted ovalbumin immunization promoted antigen-specific …

University
University of Texas Southwestern
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Bruce Beutler
Priority date
August 02, 2018
Filing date
July 31, 2019
Publication date
October 14, 2021
Language
en
Metadata fetched
August 28, 2026 19:17